{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:57:58Z","timestamp":1793404678449,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.03.007","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:24:19Z","timestamp":1775309059000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["FDG PET in pulmonary sarcoidosis: An update and future aspects"],"prefix":"10.1053","volume":"56","author":[{"given":"Ryan","family":"Donnelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-5566","authenticated-orcid":false,"given":"Niamh","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-672X","authenticated-orcid":false,"given":"David J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1053\/j.semnuclmed.2026.03.007_bib0001","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0002","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1183\/13993003.01819-2016","article-title":"Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions","volume":"48","author":"Cozier","year":"2016","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0003","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.03.007_bib0004","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. Analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on Sarcoidosis","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.03.007_bib0006","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am j respir crit care med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0007","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s41030-021-00161-w","article-title":"A comprehensive review of sarcoidosis diagnosis and monitoring for the pulmonologist","volume":"7","author":"Melani","year":"2021","journal-title":"Pulm Ther"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102652","article-title":"Challenges in diagnosis of sarcoidosis","volume":"97","author":"B\u0105czek","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.950095","article-title":"Re-evaluating serum angiotensin-converting enzyme in sarcoidosis","volume":"14","author":"Zheng","year":"2023","journal-title":"Front immunol"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front immunol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0011","first-page":"167","article-title":"Sarcoidosis: a long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis vasc diffuse lung dis: off j WASOG"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.007_bib0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-970336","article-title":"Imaging in sarcoidosis","volume":"28","author":"Nunes","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.182.2.1732948","article-title":"Pulmonary sarcoidosis: CT assessment of lesion reversibility","volume":"182","author":"Brauner","year":"1992","journal-title":"Radiology"},{"issue":"21","key":"10.1053\/j.semnuclmed.2026.03.007_bib0014","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.03.007_bib0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.007_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2002-0164PS","article-title":"Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?","volume":"27","author":"Moller","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"460","key":"10.1053\/j.semnuclmed.2026.03.007_bib0017","doi-asserted-by":"crossref","first-page":"eaar8356","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.007_bib0018","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis","volume":"115","author":"Baughman","year":"1990","journal-title":"J Lab Clin Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.007_bib0019","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00259-009-1376-6","article-title":"(18)F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis","volume":"37","author":"Keijsers","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.03.007_bib0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rmed.2012.11.011","article-title":"Severity of pulmonary involvement and 18F-FDG PET activity in sarcoidosis","volume":"107","author":"Mostard","year":"2013","journal-title":"Respir Med"},{"issue":"0","key":"10.1053\/j.semnuclmed.2026.03.007_bib0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5603\/nmr.104702","article-title":"Utility of [18F]FDG PET\/CT in sarcoidosis management: a retrospective case series","volume":"28","author":"Zekri","year":"2025","journal-title":"Nucl Med Rev"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.007_bib0023","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.03.007_bib0024","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in Cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.007_bib0025","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.007_bib0026","first-page":"1160","article-title":"Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis","volume":"39","author":"Yamada","year":"1998","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0027","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0028","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1378\/chest.14-1827","article-title":"Dual-time point whole-body 18F-fluorodeoxyglucose PET\/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB","volume":"146","author":"Maturu","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.03.007_bib0029","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.007_bib0030","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00259-009-1097-x","article-title":"18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis","volume":"36","author":"Keijsers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.03.007_bib0031","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5937\/jomb0-50994","article-title":"ACE and chitotriosidase as possible predictive biomarkers for activity of sarcoidosis in correlation with PET\/CT findings","volume":"44","author":"Stjepanovic","year":"2025","journal-title":"J Med Biochem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0033","first-page":"278","article-title":"Association between PET\/CT metabolic parameters and serum ACE and calcium levels in sarcoidosis","volume":"16","author":"Incekara","year":"2026","journal-title":"Diagn (Basel)"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","article-title":"18F-FDG PET\/CT in sarcoidosis management: review and report of 20 cases","volume":"35","author":"Braun","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.03.007_bib0036","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2967\/jnumed.121.263598","article-title":"Distinction of lymphoma from sarcoidosis on (18)F-FDG PET\/CT: evaluation of radiomics-feature-guided machine learning versus Human reader performance","volume":"63","author":"Lovinfosse","year":"2022","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.007_bib0037","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00330-024-10949-4","article-title":"Meta-analysis of [(18)F]FDG-PET\/CT in pulmonary sarcoidosis","volume":"35","author":"Donnelly","year":"2025","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0038","doi-asserted-by":"crossref","first-page":"e222483","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.03.007_bib0039","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00415-009-5270-8","article-title":"18F-FDG PET successfully detects spinal cord sarcoidosis","volume":"256","author":"Ota","year":"2009","journal-title":"J Neurol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/17476348.2020.1684902","article-title":"Emerging phenotypes of sarcoidosis based on 18F-FDG PET\/CT: a hierarchical cluster analysis","volume":"14","author":"Papiris","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"155","key":"10.1053\/j.semnuclmed.2026.03.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0145-2019","article-title":"Clinical phenotyping: role in treatment decisions in sarcoidosis","volume":"29","author":"Baughman","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.03.007_bib0042","doi-asserted-by":"crossref","first-page":"2500943","DOI":"10.1183\/13993003.00943-2025","article-title":"Pulmonary sarcoidosis clinical trial end-points: a Delphi study","volume":"66","author":"Baughman","year":"2025","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0043","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.03.007_bib0044","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hlc.2019.07.007","article-title":"The utility of whole body (18)F-FDG PET-CT in diagnosing isolated cardiac sarcoidosis: the Western Australian cardiac sarcoid study","volume":"29","author":"Giudicatti","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0045","article-title":"Deciphering the role of FDG-PET\/CT in the management of sarcoidosis","author":"Donnelly","year":"2025","journal-title":"CHEST"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0046","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2025","article-title":"Sarcoidosis: a state-of-the-art review","volume":"67","author":"Miedema","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0047","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fmed.2023.1174518","article-title":"From Karl Wurm and Guy Scadding's staging to 18F-FDG PET\/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis","volume":"Volume 10","author":"Papiris","year":"2023","journal-title":"Front Med"},{"issue":"Supplement_6","key":"10.1053\/j.semnuclmed.2026.03.007_bib0048","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1513\/AnnalsATS.201707-566OT","article-title":"High-risk sarcoidosis. Current concepts and research imperatives","volume":"14","author":"Sauer","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"169","key":"10.1053\/j.semnuclmed.2026.03.007_bib0049","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2023","article-title":"Sarcoidosis-associated pulmonary fibrosis: joining the dots","volume":"32","author":"Bandyopadhyay","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0050","doi-asserted-by":"crossref","first-page":"107165","DOI":"10.1016\/j.crad.2025.107165","article-title":"Radiomics in clinical radiology: advances, challenges, and future directions","volume":"92","author":"Linton-Reid","year":"2026","journal-title":"Clin Radiol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.03.007_bib0051","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11604-024-01546-y","article-title":"Machine learning approach using 18F-FDG-PET-radiomic features and the visibility of right ventricle 18F-FDG uptake for predicting clinical events in patients with cardiac sarcoidosis","volume":"42","author":"Nakajo","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0052","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232459","article-title":"What a radiologist needs to know about radiomics, standardization, and reproducibility","volume":"310","author":"Huisman","year":"2024","journal-title":"Radiology"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.03.007_bib0053","article-title":"Non-invasive procedure in differential diagnosis of sarcoidosis and tuberculosis lymph nodes: radiomic model of 18F-FDG PET-CT","volume":"42","author":"Ser\u00e7e Unat","year":"2025","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2026.03.007_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2025.02.017","article-title":"Deciphering the role of FDG-PET\/CT imaging in the management of sarcoidosis","author":"Donnelly","year":"2025","journal-title":"Chest"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:30:11Z","timestamp":1792585811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826000759"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.03.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG PET in pulmonary sarcoidosis: An update and future aspects","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}